About: The plasminogen activator system in women with polycystic ovary syndrome

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: The plasminogen activator system in women with polycystic ovary syndrome Goto Sponge Distinct Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

scientific article published on 01 February 1998

Attributes	Values
rdf:type	Item
description	wetenschappelijk artikel (nl) наукова стаття, опублікована в лютому 1998 (uk) im Februar 1998 veröffentlichter wissenschaftlicher Artikel (de) artículu científicu espublizáu en febreru de 1998 (ast) artikull shkencor i botuar më 01 shkurt 1998 (sq) scientific article published on 01 February 1998 (en)
publication date	wds:Q74296167-66F926D2-74B6-4D4D-BCF4-128B99976CA8
publication date	1998-02-01 00:00:00Z (xsd:dateTime)
language of work or name	wds:Q74296167-C031E90E-84C1-4AA6-B621-60AC4F655BEC
language of work or name	English
cites work	wds:Q74296167-1C799358-0B16-41B3-82A7-528804B8518E wds:Q74296167-1F645C71-2D77-433A-A224-106AB1D93815 wds:Q74296167-27921457-5858-44F0-8D8B-C658B8466432 wds:Q74296167-5B50FD17-077E-4732-A2C0-D6B9403B4077 wds:Q74296167-5E8C631E-B73F-4479-8CF5-AA18B64D290C wds:Q74296167-7D36FF9A-9528-412C-A038-5AE52F51FA5C wds:Q74296167-8FF4EE3A-FDE0-446D-A73D-6399DA13CDBA wds:Q74296167-9F332E6F-476A-47AA-9B53-8AE04C3D1D2A wds:Q74296167-A920612A-6D8C-4C9D-8D9D-A566641E2640 wds:Q74296167-DC9E079F-B30A-425D-B423-441548DBED8E wds:Q74296167-E4820695-8F50-4E8B-A180-35420B68C893 wds:Q74296167-ED3A522B-2036-4A73-873E-C5EAE53B65A5 wds:Q74296167-FD75AA0A-3EEA-4299-9049-BE4ECFFA2026
cites work	Ambulatory blood pressure profiles and plasminogen activator inhibitor (PAI-1) activity in lean women with and without the polycystic ovary syndrome. Increased insulin sensitivity and fibrinolytic capacity after dietary intervention in obese women with polycystic ovary syndrome. Regulation of 72-kd type IV collagenase-matrix metalloproteinase-2 by estradiol and gonadotropin-releasing hormone agonist in human granulosa-lutein cells Clinical assessment of body hair growth in women Plasminogen activators in tissue remodeling and invasion: mRNA localization in mouse ovaries and implanting embryos Recurrent early miscarriage and polycystic ovaries Follicular plasminogen and plasminogen activator and the effect of plasmin on ovarian follicle wall Medical implications of ultrasonically detected polycystic ovaries Fibrinolytic activity and clotting factors in ischaemic heart disease in women Fat distribution and plasminogen activator inhibitor activity in nondiabetic obese women Pulsatile luteinizing hormone-releasing hormone therapy in women with polycystic ovary syndrome Fibrinolytic pattern in recurrent spontaneous abortions: no relationship between hypofibrinolysis and anti-phospholipid antibodies Fluid Characteristics of Benign Ovarian Cysts: Correlation With Recurrence After Puncture
author name string	wds:Q74296167-648AB20B-0EEB-421E-AA13-A0835E99C031 wds:Q74296167-A84892DE-46B3-48E6-99D4-0525966C3E50 wds:Q74296167-C23B82CB-F114-4A18-BB9C-3B41FA495647 wds:Q74296167-D40C3A26-D36C-444D-ACBE-A99B5533B29E wds:Q74296167-F03A2A4A-1C38-4C7B-9B17-3B1775D0C0C0
author name string	S Shaw A G Prentice S A Bates J E Condon J H West
rdfs:label	The plasminogen activator system in women with polycystic ovary syndrome (en) The plasminogen activator system in women with polycystic ovary syndrome (nl) The plasminogen activator system in women with polycystic ovary syndrome (sq)
skos:prefLabel	The plasminogen activator system in women with polycystic ovary syndrome (en) The plasminogen activator system in women with polycystic ovary syndrome (nl) The plasminogen activator system in women with polycystic ovary syndrome (sq)
name	The plasminogen activator system in women with polycystic ovary syndrome (en) The plasminogen activator system in women with polycystic ovary syndrome (nl) The plasminogen activator system in women with polycystic ovary syndrome (sq)
author	wds:Q74296167-9FEF1254-A49C-42A5-A522-04379422DDB9
author	William Atiomo
title	wds:Q74296167-63463138-013C-45D0-B5BB-2831DBE93C5E
title	The plasminogen activator system in women with polycystic ovary syndrome (en)
page(s)	wds:Q74296167-233C623B-FFD7-4EAD-B342-351FDF98224F
page(s)	236-241
instance of	wds:Q74296167-8E7FA87E-70FC-4637-ACDC-88B717368D69
instance of	scholarly article
main subject	wds:Q74296167-06F8E7C5-2208-4B12-B03F-56968A03834B wds:Q74296167-55887563-D96A-4F68-A5C6-FB6FE4E93509 wds:Q74296167-CECE0179-4C1C-40E3-8FE8-2EDED2AD1854
main subject	plasminogen polycystic ovary syndrome polycystic ovary
PubMed ID	wds:Q74296167-26E5257E-2B6C-4F08-8374-8F7D9F88C104
PubMed ID	http://rdf.ncbi.nlm.nih.gov/pubchem/reference/9496335
PubMed ID	9496335
published in	wds:Q74296167-AA71F91B-123A-4BA4-BC8B-D8628EA6BEC4
published in	Fertility and Sterility
issue	wds:Q74296167-71D43B36-5828-4A16-B9BA-FE3DF088E2C9
volume	wds:Q74296167-F0EB59D3-75D8-4ED6-AAA0-06034B270709
issue	2
volume	69
DOI	wds:Q74296167-AA24C66B-B255-47CB-82DD-A6D409E23967
DOI	http://dx.doi.org/10.1016/S0015-0282(97)00486-X
DOI	10.1016/S0015-0282(97)00486-X
is about of	https://www.wikidata.org/wiki/Special:EntityData/Q74296167
is cites work of	Continuing metformin throughout pregnancy in women with polycystic ovary syndrome appears to safely reduce first-trimester spontaneous abortion: a pilot study Cardiovascular risk in women with polycystic ovary syndrome. Cardiovascular risk in women with polycystic ovarian syndrome (PCOS) Apolipoprotein E gene polymorphism and polycystic ovary syndrome patients in Western Anatolia, Turkey Diastolic dysfunction and increased serum homocysteine concentrations may contribute to increased cardiovascular risk in patients with polycystic ovary syndrome. Cardiometabolic aspects of polycystic ovarian syndrome. The importance of insulin resistance in polycystic ovary syndrome Insulin-Lowering Agents in the Management of Polycystic Ovary Syndrome Prevalence of metabolic syndrome and related characteristics in obese adolescents with and without polycystic ovary syndrome Cardiometabolic aspects of the polycystic ovary syndrome. PAI-1 in granulosa cells is suppressed directly by statin and indirectly by suppressing TGF-β and TNF-α in mononuclear cells by insulin-sensitizing drugs The plasminogen activator inhibitor-1 (PAI-1) gene -844 A/G and -675 4G/5G promoter polymorphism significantly influences plasma PAI-1 levels in women with polycystic ovary syndrome Recurrent pregnancy loss in polycystic ovary syndrome: role of hyperhomocysteinemia and insulin resistance Correction of hyperinsulinemia in oligoovulatory women with clomiphene-resistant polycystic ovary syndrome: a review of therapeutic rationale and reproductive outcomes Polycystic ovary syndrome--a systemic disorder? Familial associations in women with polycystic ovary syndrome Plasminogen activator inhibitor-1 -675 4G/5G polymorphism and polycystic ovary syndrome risk: a meta analysis

Faceted Search & Find service v1.16.117 as of May 05 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 172 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software